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Anthrax toxins cause vascular dysfunction, in part by perturbing the endothelial cell barrier. Reporting in
Nature, Guichard et al. shed new light on the mechanism by which this occurs and show that anthrax toxins
interferewith exocytic delivery of cadherins to endothelial cell junctionsby antagonizing the exocyst complex.The bacterium Bacillus anthracis is the
causative agent of anthrax—an often
lethal disease characterized by vascular
collapse (Moayeri and Leppla, 2009).
Two toxins, lethal toxin (LT) and edema
toxin (ET), play critical roles in systemic
anthrax. The toxic moieties of LT and ET
are known as lethal factor (LF) and edema
factor (EF), respectively. LF is zinc-depen-
dent metalloprotease that cleaves MAP
kinase kinase (MAPKK) proteins, thereby
interfering with cellular signal transduc-
tion pathways. EF is a calmodulin-depen-
dent adenylate cyclase that affects cell
physiology by elevating cyclic AMP
(cAMP) levels. Vascular endothelial cells
are thought to be an important target for
LT and ET, as adverse effects on the
barrier function of these cells could, in
part, account for the vascular leakage
that typifies systemic anthrax (Moayeri
and Leppla, 2009). Indeed, LT causes
a loss of endothelial cell barrier function
(Warfel et al., 2005). Interestingly, LT-
mediated inhibition of barrier function is
correlated with decreased surface ex-
pression of the adherens junction protein,
vascular endothelial cadherin. Altogether
these findings suggest that LT and
perhaps ET might impair the function of
vascular endothelium, in part by downre-gulating a key molecule involved in cell-
cell adhesion. However, the molecular
mechanism bywhich anthrax toxins affect
cadherin distribution in endothelial cells
was not understood. Recent findings by
Guichard and colleagues (2010), pub-
lished in Nature, have shed light on this
important topic. The authors found that
LT and ET impair the delivery of cadherins
from intracellular vesicles to adherens
junctions. These toxins perturb trafficking
by interfering with the function of a multi-
protein complex called the exocyst.
The exocyst is an evolutionarily con-
served eight-subunit complex comprised
of Sec3, Sec5, Sec6, Sec8, Sec10,
Sec15, Exo70, and Exo84 (Wu et al.,
2008). This complex promotes exocytosis
by mediating tethering and fusion of intra-
cellular vesicles with sites in the plasma
membrane. Exocyst activity is regulated
by several small GTPases, including
Rab11, which interacts with Sec15 and
mediates the transport of vesicles from
a specialized endosomal compartment
called the recycling endosome to the
plasma membrane. The route that led
to the discovery that anthrax toxins
antagonize the exocyst is fascinating and
serves as a prime example of how
simplified animal models can be usefulin understandingbacterial virulencemech-
anisms. In previous work, the same group
expressed EF and LF in Drosophila mela-
nogaster and found that these
toxins caused phenotypes consistent
with their known effects on MAP kinase-
and cAMP-mediated signaling (Guichard
et al., 2006). These initial findings sug-
gested that EF and LF are active in the fruit
fly and that this organism might therefore
beausefulmodel for probing thebiological
function of anthrax toxins. In their current
study, Guichard et al. (2010) found that,
when expressed in Drosophila, EF or LF
elicit phenotypes that resemble inhibition
of the Notch signaling pathway (Fortini,
2009). A previous study by another group
indicated a role for Rab11 and Sec15 in
plasma membrane delivery of the Notch
ligand Delta (Jafar-Nejad et al., 2005).
Inspired by these findings, Guichard and
colleagues performed a series of elegant
genetic studies leading to the conclusion
that EF interferes with Notch signaling
by antagonizing Rab11. Both EF and LF
were found to impair the formation
of Sec15-containing vesicles and the
delivery of DE-cadherin to adherens
junctions in Drosophila cells. The authors’
findings inDrosophila led them to examine
the effect of anthrax toxins on exocyticovember 16, 2010 ª2010 Elsevier Inc. 643
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Previewsdelivery of cadherins to cell junctions in
human cells.
In cultured human cells, Guichard and
colleagues found that LT or ET each
blocked the formation of large Sec15-
positive vesicles, suggesting that the
toxins interfere with exocyst-mediated
trafficking to the plasma membrane.
Although both toxins perturbed Sec15
localization, only ET inhibited the accu-
mulation of Rab11-positive vesicles.
These findings suggest that at least one
of the ways that ET impairs the exocyst
is by affecting Rab11 localization. In
contrast, LT inhibits Sec15 by acting
downstream of Rab11. Importantly, the
effects of ET and LT on Sec15 localization
coincided with a depletion of cadherins at
cell junctions. In addition, ET caused
increased permeability of cultured endo-
thelial cells. Altogether, the results sug-
gest that ET and LT can compromise
endothelial cell function by interfering
with Sec15, thereby blocking exocytic
delivery of cadherins to cell junctions.
The results from this study raise several
interesting questions. First, are the effects
of EF and LF on the Rab11-regulated644 Developmental Cell 19, November 16, 20exocyst due to the known activities of
these toxins in antagonizing MAPKK iso-
forms and/or activating cAMP-dependent
signaling? This question could be ad-
dressed by using catalytically inactive
toxin mutants (Tonello and Montecucco,
2009; Shen et al., 2005), chemical inhibi-
tors of these toxins (Tonello and Monte-
cucco, 2009; Shen et al., 2004), and
chemical inhibitors of the MAPK pathway
(Warfel et al., 2005). Second, if pharmaco-
logical inhibition of the MAPK pathway
is not found to mirror the effects of LF
on the Rab11-controlled exocyst, then
do novel LF substrates exist? Could
Drosophila be used to identify these
substrates, perhaps by searching for
mutations that suppress an LF-induced
Notch phenotype? Finally, could Notch
and its ligands be physiological targets
of anthrax toxins in human endothelial
cells? If so, what aspects of endothelial
cell function are affected through toxin-
mediated perturbation of the Notch
pathway? Future studies in Drosophila
seem likely to provide additional novel
insights into the biological activities of
anthrax toxins.10 ª2010 Elsevier Inc.REFERENCES
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Recent work in animals and plants suggests that reactive oxygen species (ROS) control cell proliferation.
Reporting in Cell, Tsukagoshi et al. (2010) identify UPBEAT1 as a key transcription factor in the regulation
of ROS distribution, which they find controls the transition between cell proliferation and differentiation in
the Arabidopsis root.Reactive oxygen species (ROS) have
been implicated in many physiological
processes in plants and animals, includ-
ing cell signaling and pathogen defense
responses. Recent work in animal model
systems has highlighted a role for ROS
control of cell proliferation (Theopold,
2009). In Drosophila, for example, ROS
prime hematopoietic progenitors for dif-ferentiation (Owusu-Ansah and Banerjee,
2009). In the model plant Arabidopsis
thaliana, two of themain ROS, superoxide
(O2
d) and hydrogen peroxide (H2O2),
exhibit distinct patterns of distribution in
root tissues (Dunand et al., 2007). O2
d
and H2O2 mainly accumulate in dividing
and expanding cells in the meristem and
elongation zones, respectively, and over-lap within the ‘‘transition zone’’ (Figure 1).
Other studies have described how redox
regulation plays an important role in main-
taining plant cell proliferation (Vernoux
et al., 2000). However, regulators con-
trolling ROS gradients and cell differentia-
tion remain to be identified in animals or
plants. In a recent issue of Cell, Tsuka-
goshi et al. (2010) report that the balance
